Mark Hudson | Senior Manager, Investor Relations |
Leonard Schleifer | Founder, President & Chief Executive Officer |
George Yancopoulos | Founding Scientist, President & Chief Scientific Officer |
Marion McCourt | Senior Vice President & Head of Commercial |
Bob Landry | Executive Vice President & Chief Financial Officer |
Ying Huang | Bank of America Merrill Lynch |
Chris Raymond | Piper Jaffray |
Geoffrey Porges | SVB Leerink |
Terence Flynn | Goldman Sachs |
Carter Gould | UBS |
Geoff Meacham | Barclays |
Cory Kasimov | JPMorgan |
Adnan Butt | Guggenheim Securities |
Robyn Karnauskas | Citi |
Welcome to the Regeneron Pharmaceuticals Fourth Quarter 2018 Earnings Conference Call. My name is Paulette and I will be your operator for today’s call. At this time, all participants are in listen-only mode. Later, we will conduct a question-and-answer session. [Operator Instructions] Please note that this conference is being recorded.